FLNA Filana Therapeutics, Inc.

Fundamentals / CIK 0001069530 / USD

Filana Therapeutics, Inc. reported $100.1M in total assets and a net loss of $42.20M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FLNA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$90.90MFY 2016 Net Income: -$14.85M2016FY 2017 Net Income: -$11.91M2017FY 2018 Net Income: -$6.56M2018FY 2019 Net Income: -$4.63M2019FY 2020 Net Income: -$6.33M2020FY 2021 Net Income: -$32.38M2021FY 2022 Net Income: -$76.25M2022FY 2023 Net Income: -$97.22M2023FY 2024 Net Income: -$24.34M2024FY 2025 Net Income: -$90.97M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $26.59M $69.64M $89.42M $68.03M $24.81M -- -- $2.97M $7.62M $9.18M
Total Operating Expenses $95.39M $141.4M $106.0M $80.02M $32.87M $6.45M $4.96M $6.66M $11.95M $14.96M
Operating Income -$95.39M -$141.4M -$106.0M -$80.02M -$32.87M -$6.45M -$4.96M -$6.66M -$11.95M -$14.96M
EBITDA -$94.45M -$140.3M -$104.4M -$78.72M -$32.33M -$6.42M -$4.90M -$6.59M -$11.88M -$14.90M
Income Tax Expense $0 $0 -- -- -- -- -- -- -- --
Net Income -$90.97M -$24.34M -$97.22M -$76.25M -$32.38M -$6.33M -$4.63M -$6.56M -$11.91M -$14.85M
Basic EPS -$1.88 -$0.53 -$2.32 -$1.90 -$0.82 -$0.24 -$0.27 -$0.61 -$1.82 -$2.28
Diluted EPS -$1.88 -$1.46 -$2.32 -$1.90 -$0.82 -$0.24 -$0.27 -$0.61 -$1.82 -$2.28
Basic Shares Outstanding 48.3M 46.3M 41.9M 40.2M 39.4M 26.1M 17.4M 10.7M 6.5M 6.5M
Diluted Shares Outstanding 48.3M 46.6M 41.9M 40.2M 39.4M 26.1M 17.4M 10.7M 6.5M 6.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $3.87M $3.30M $4.54M $3.85M $3.96M $5.12M $13.67M $20.53M
Total Operating Expenses $11.27M $9.39M $11.17M $13.55M $11.86M $45.39M $24.59M $29.49M
Operating Income -$11.27M -$9.39M -$11.17M -$13.55M -$11.86M -$45.39M -$24.59M -$29.49M
EBITDA -$11.07M -$9.09M -$10.93M -$13.22M -$11.66M -$45.19M -$24.37M -$29.38M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$10.73M -$8.60M -$10.33M -$12.54M -$10.81M -$44.22M -$23.40M -$27.60M
Basic EPS -$0.22 -$0.18 -$0.21 -- -$0.22 -$0.92 -$0.48 --
Diluted EPS -- -- -- -- -$0.22 -$0.92 -$0.48 --
Basic Shares Outstanding -- -- -- -- 48.3M 48.3M 48.3M --
Diluted Shares Outstanding -- -- -- -- 48.3M 48.3M 48.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $95.50M $128.6M $121.1M $201.0M $233.4M $93.51M $23.08M $19.81M $10.48M $16.61M
Short-Term Investments -- -- -- -- -- -- -- -- -- $2.10M
Cash & Short-Term Investments $95.50M $128.6M $121.1M $201.0M $233.4M $93.51M $23.08M $19.81M $10.48M $18.71M
Other Current Assets $64K $38K $287K $160K -- $488K $268K $233K $184K $356K
Total Current Assets $97.71M $136.5M $129.6M $211.2M $244.5M $93.99M $23.35M $20.04M $10.66M $19.07M
Property, Plant & Equipment, Net $20.65M $21.00M $21.85M $22.86M $20.62M $11K $47K $87K $156K $232K
Intangible Assets $193K $37K $176K $622K $1.07M $1.07M -- -- -- --
Other Non-Current Assets -- -- -- -- $399K -- -- $12K $12K --
Total Non-Current Assets $20.65M $21.00M $22.03M $23.61M $22.30M $306K $137K $99K $168K $232K
Total Assets $118.4M $157.5M $151.7M $234.8M $266.8M $94.30M $23.49M $20.14M $10.83M $19.30M
Accounts Payable -- -- -- $4.02M $7.13M $911K $453K $294K $424K $303K
Other Current Liabilities $198K $299K $385K $492K $631K $94K $9.0K -- -- --
Total Current Liabilities $43.83M $11.75M $14.20M $7.06M $12.53M $1.86M $1.39M $511K $1.13M $665K
Other Non-Current Liabilities $118K $79K $0 $197K $194K -- -- -- -- --
Total Non-Current Liabilities $118K $79K $0 $232K $333K $235K $0 $0 $0 $0
Total Liabilities $43.95M $11.83M $14.20M $7.29M $12.87M $2.10M $1.39M $511K $1.13M $665K
Total Debt (incl. Leases) -- -- -- $139K $236K $293K $90K -- -- --
Common Stock $48K $48K $42K $42K $40K $35K $22K $17K $7.0K $7.0K
Retained Earnings -$496.1M -$405.1M -$380.8M -$283.6M -$207.3M -$174.9M -$168.6M -$164.0M -$157.4M -$145.5M
Total Stockholders' Equity $74.40M $145.7M $137.5M $227.5M $253.9M $92.20M $22.10M $19.63M $9.70M $18.64M
Total Equity $74.40M $145.7M $137.5M $227.5M $253.9M $92.20M $22.10M $19.63M $9.70M $18.64M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $46.99M $82.68M $86.57M $95.50M $106.1M $112.4M $117.3M $128.6M
Cash & Short-Term Investments $46.99M $82.68M $86.57M $95.50M $106.1M $112.4M $117.3M $128.6M
Other Current Assets $170K $198K $220K $64K $106K $134K $162K $38K
Total Current Assets $80.06M $83.72M $87.96M $97.71M $108.9M $114.8M $120.2M $136.5M
Property, Plant & Equipment, Net $20.00M $20.18M $20.40M $20.65M $20.82M $20.56M $20.78M $21.00M
Intangible Assets -- -- -- $193K -- -- -- $37K
Total Non-Current Assets $20.00M $20.18M $20.40M $20.65M $20.82M $20.56M $20.78M $21.00M
Total Assets $100.1M $103.9M $108.4M $118.4M $129.7M $135.4M $140.9M $157.5M
Other Current Liabilities $157K $121K $75K $198K $226K $159K $113K $299K
Total Current Liabilities $41.95M $40.16M $40.12M $43.83M $48.05M $47.33M $13.24M $11.75M
Other Non-Current Liabilities $136K $136K $111K $118K $119K $79K $79K $79K
Total Non-Current Liabilities $136K $136K $111K $118K $119K $79K $79K $79K
Total Liabilities $42.08M $40.29M $40.23M $43.95M $48.16M $47.41M $13.32M $11.83M
Common Stock $50K $48K $48K $48K $48K $48K $48K $48K
Retained Earnings -$525.7M -$515.0M -$506.4M -$496.1M -$483.5M -$472.7M -$428.5M -$405.1M
Total Stockholders' Equity $57.98M $63.61M $68.14M $74.40M $81.57M $87.97M $127.6M $145.7M
Total Equity $57.98M $63.61M $68.14M $74.40M $81.57M $87.97M $127.6M $145.7M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$90.97M -$24.34M -$97.22M -$76.25M -$32.38M -$6.33M -$4.63M -$6.56M -$11.91M -$14.85M
Depreciation & Amortization $936K $1.13M $1.53M $1.30M $534K $22K $58K $69K $68K $58K
Stock-Based Compensation $19.58M $16.29M $4.59M $2.07M $1.76M $988K $1.30M $2.39M $2.97M $4.33M
Change in Payables $33.99M -$2.92M $6.90M -$3.45M $6.21M $458K $159K -$130K $129K -$711K
Operating Cash Flow -$32.25M -$116.9M -$82.03M -$77.51M -$30.20M -$5.38M -$2.51M -$4.77M -$8.24M -$12.23M
Capital Expenditure -$581K -$103K -$414K -$2.71M -$22.21M -- -$18K -- -- -$75K
Free Cash Flow -$32.83M -$117.0M -$82.44M -$80.23M -$52.41M -- -$2.53M -- -- -$12.31M
Purchases of Investments -- -- -- -- -- -- -- -- -$399K -$4.14M
Investing Cash Flow -$581K -$103K -$414K -$2.71M -$22.21M $360K -$18K -- $2.10M -$2.17M
Common Stock Issued -- $0 $0 $47.33M $189.8M $70.25M -- $14.10M -- --
Financing Cash Flow -$239K $124.5M $2.56M $47.80M $192.3M $75.45M $5.81M $14.10M -- -$284K
Net Change in Cash -$33.07M $7.44M -$79.88M -$32.42M $139.9M $70.42M $3.27M $9.33M -$6.14M -$14.68M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$10.73M -$8.60M -$10.33M -$12.54M -$10.81M -$44.22M -$23.40M -$27.60M
Depreciation & Amortization $200K $300K $243K $334K $200K $200K $220K $112K
Stock-Based Compensation $3.48M $4.07M $4.07M $5.37M $4.40M $4.58M $5.22M $5.74M
Operating Cash Flow -$6.09M -$3.85M -$8.88M -$9.75M -$6.22M -$4.95M -$11.34M -$61.27M
Capital Expenditure -- -- -- -$501K -$80K $0 $0 -$57K
Free Cash Flow -- -- -- -$10.25M -$6.30M -$4.95M -$11.34M -$61.32M
Investing Cash Flow -- -- -- -$501K -$80K $0 $0 -$57K
Financing Cash Flow $1.68M -$16K -$51K -$329K $0 $0 $90K $918K
Net Change in Cash -$4.44M -$3.89M -$8.93M -$10.58M -$6.30M -$4.95M -$11.25M -$60.40M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -122.3% -16.7% -70.7% -33.5% -12.8% -6.9% -21.0% -33.4% -122.8% -79.7%
Return on Assets (ROA) -76.9% -15.5% -64.1% -32.5% -12.1% -6.7% -19.7% -32.6% -110.0% -76.9%
Current Ratio 2.23x 11.62x 9.13x 29.91x 19.51x 50.40x 16.83x 39.22x 9.42x 28.68x
Quick Ratio 2.18x 10.94x 8.53x 28.46x 18.62x 50.14x 16.64x 38.76x 9.26x 28.14x
Debt to Equity -- -- -- 0.00x 0.00x 0.00x 0.00x -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -- -- -112.5% -- --
10Y Net Income / Share Growth -- -- -147.3% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -72.8% -66.5% -114.3% -122.3% -130.0% -140.0% -57.0% -16.7%
Return on Assets (ROA) -42.2% -40.7% -71.9% -76.9% -81.7% -91.0% -51.6% -15.5%
Current Ratio 1.91x 2.08x 2.19x 2.23x 2.27x 2.43x 9.08x 11.62x
Quick Ratio 1.12x 2.06x 2.16x 2.18x 2.21x 2.37x 8.86x 10.94x
Net Income Growth (YoY) -- -- -- -- -- -818.5% -193.5% --
EPS Growth (YoY) -- -- -- -- -- -807.7% -182.8% --
Source: SEC EDGAR CompanyFacts (CIK 0001069530) · from December 31, 2009 Data through September 30, 2026 · synced Nov 21, 2026, 05:03 UTC · Open in terminal